Corbadrine
![]() | |
Systematic (IUPAC) name | |
---|---|
4-[(1R,2S)-2-amino-1-hydroxypropyl]benzene-1,2-diol | |
Clinical data | |
| |
Identifiers | |
829-74-3 ![]() | |
None | |
PubChem | CID 164739 |
IUPHAR ligand | 508 |
DrugBank |
DB06707 ![]() |
ChemSpider |
144416 ![]() |
UNII |
V008L6478D ![]() |
KEGG |
D02388 ![]() |
ChEMBL |
CHEMBL677 ![]() |
Chemical data | |
Formula | C9H13NO3 |
183.204 g/mol | |
SMILES
| |
| |
![]() |
Corbadrine (INN; marketed as Neo-Cobefrine), also known as levonordefrin (USAN) and α-methylnorepinephrine, is a catecholamine sympathomimetic used as a topical nasal decongestant and vasoconstrictor in dentistry in the United States.[1][2]
Corbadrine is also an active metabolite of the antihypertensive drug methyldopa, and plays a role in its pharmacology and effects.
See also
- α-Methyldopamine
- α-Methyltyramine
References
- ↑ Dr. Ian Morton; I.K. Morton; Judith M. Hall (31 October 1999). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 164–. ISBN 978-0-7514-0499-9.
- ↑ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 275–. ISBN 978-3-88763-075-1.
External links
- Nordefrin at the US National Library of Medicine Medical Subject Headings (MeSH)
|
|
|